Effects on pulmonary function of two regimens of chemotherapy for AIDS related Kaposi's sarcoma

Clinical Oncology

Volumn 8, Issue 1, 1996, Pages 48-50

  Denton, A S ^a   Simpson, J K ^a   Hallam, M ^a   Spittle, M F ^a   Miller, R F ^a,b  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AIDS; Chemotherapy; Kaposi's sarcoma; Pulmonary function

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC ALKALOID; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; CARBON MONOXIDE; DOXORUBICIN; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0029883831     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(05)80039-1     Document Type: Article

References (7)

1. Hoover DR, Black C, Jacobson LP, et al. Analysis of Kaposi's sarcoma as an early or late outcome in HIV affected men. Am J Epidemiol 1993;138:266-78.
2. Gompels MM, Hill A, Jenkins P, et al. Kaposi' sarcoma in HIV infection treated with bleomycin and vincristine. AIDS 1992;6:1175-80.
3. Simpson JK, Miller RF, Spittle MF. Liposomal doxorubicin in the treatment of AIDS related Kaposi's sarcoma. J Clin Oncol 1993;12:1130-6.
4. Hengge UR, Brockmeyer NH, Rabhofer R, et al. Hepatic failure withliposomal doxorubicin. Lancet 1993;341:383-4.
5. Pascual PS, Mosher MB, Sikand RS, et al. Effects of bleomycin on pulmonary function in man. Am Rev Respir Dis 1973;108:211-7.
6. Miller RF, Tomlinson MC, Cottril CP, et al. Broncho-pulmonary Kaposi's sarcoma in patients with AIDS. Thorax 1992;47:721-5.
7. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immunodeficiency syndrome: A proposal for uniform evaluation, response and staging criteria. J Clin Oncol 1989;7:1201-7.